Starry Pharmaceutical

Zhejiang Starry Pharmaceutical Co., Ltd., established in 1997 and based in Xianju, China, specializes in the research, development, manufacturing, and marketing of active ingredients and intermediates for X-CT non-ionic contrast agents and fluoroquinolones. The company's range of contrast medium products includes various formulations of iohexol, ioversol, iopamidol, and gadolinium-based agents, among others. In addition to its contrast agents, Starry Pharmaceutical produces fluoroquinolones such as levofloxacin and pazufloxacin. The company is recognized as a national high-tech enterprise, highlighting its commitment to innovation and quality in the pharmaceutical sector, both in China and internationally.